HeartBeam (BEAT)
(Delayed Data from NSDQ)
$2.07 USD
-0.04 (-1.90%)
Updated May 17, 2024 04:00 PM ET
After-Market: $2.07 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
BEAT 2.07 -0.04(-1.90%)
Will BEAT be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for BEAT based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for BEAT
HeartBeam AIMIGoâ„¢ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program
HeartBeam, Inc. 2024 Q1 - Results - Earnings Call Presentation
HeartBeam, Inc. (BEAT) Q1 2024 Earnings Call Transcript
HeartBeam Reports First Quarter 2024 Results
BEAT Stock Earnings: HeartBeam Misses EPS for Q1 2024